Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association
The outcomes of this research pointed out a lot of misinformation surrounding AIT, calling for improvements in awareness and information on its efficacy and safety. Also, we noted a significant reduction in work/school days lost in patients who completed AIT and a good patient-reported safety and efficacy profile. We advocate for better economic accessibility through national-level standardization in treatment refundability. Notably, the collaboration with the patient association was crucial, and it would have been challenging to conduct this research otherwise.
Authors
- Daniele Diso (ORCID: https://orcid.org/0000-0002-4514-0678)
- Mattia Giovannini (ORCID: https://orcid.org/0000-0001-9568-6882)
- Domenico Gargano (ORCID: https://orcid.org/0000-0003-4677-3730)
- Luca Pecoraro (ORCID: https://orcid.org/0000-0002-9765-8006)
- Simona Barbaglia
- Maria Chiara Bragato (ORCID: https://orcid.org/0000-0002-6659-4409)
- Giorgio Walter Canonica (ORCID: https://orcid.org/0000-0001-8467-2557)
- P Valli (ORCID: https://orcid.org/0000-0001-8335-547X)
- Emanuele Nappi (ORCID: https://orcid.org/0000-0003-1458-4863)
- Enrico Marco Heffler (ORCID: https://orcid.org/0000-0002-0492-5663)
- Giovanni Paoletti (ORCID: https://orcid.org/0000-0003-3953-9225)
Institutions
- University of Verona (IT)
- Humanitas University (IT)
- Azienda Ospedaliera S.Giuseppe Moscati (IT)
- Meyer Children's Hospital (IT)
- ANT Foundation Italy Onlus (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- University of Florence (IT)
Publication Details
- Journal
- World Allergy Organization Journal
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.waojou.2024.101015
- Citations
- 4
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 1.53
Funders
- Ashikaga Institute of Technology